The Basil Hetzel Institute for Translational Health Research (BHI) is the productive research arm of The Queen Elizabeth Hospital and home to almost 200 researchers and research administrative staff.

The BHI provides a dynamic, state-of-the-art research environment for vital ‘bench to bedside’ research and research training opportunities. Affiliated with the Universities of Adelaide, Flinders and the University of South Australia, the BHI is a short walk from The Queen Elizabeth Hospital, allowing for a vital and active interface between researchers and clinicians.

All research groups have strong links to clinical divisions within the Hospital underpinning The Institute’s overarching focus on translational health research. This ‘bench to bedside’ approach is at the forefront of an emerging area of medical science that aims to improve public health through collaborative discoveries and innovations in patient care, education and research.

Research conducted by The Institute covers a broad spectrum, exploring causes, potential improvements in therapeutic outcomes and the prevention of some of the most serious and common health conditions facing our community today.

Research areas include;

  • Ageing
  • Cancer – breast cancer, colorectal (bowel) cancer, liver metastasis, prostate and oesophageal cancer
  • Cardiovascular Disease
  • Chronic Disease
  • Clinical Sciences, Health services and Population Health
  • Drug and Vaccine Development
  • Inflammatory Disease


The Basil Hetzel Institute for Translational Health Research is home to almost 200 researchers and administrative staff.

Opened in 2009, the facility was proudly named after the first Professor of Medicine at the hospital and one of Australia’s leading medical researchers, the late Honourable Basil Hetzel AC. Revered world-wide for his pioneering work which discovered the link between iodized salt in the diet and the prevention of brain damage in newborns, Dr Hetzel’s groundbreaking research has helped millions of children in 130 countries where iodine is lacking.

His passion and drive to prevent brain damaged babies born as a result of iodine deficiency around the world has been recognized as one of the most significant medical discoveries of modern times.

Dr Hetzel has received numerous academic and humanitarian awards, not only for his landmark medical research but for his commitment, vision and leadership in the areas of public and community health.

His strong support for the translational medical research undertaken at the facility which proudly bears his name continues to inspire current researchers and those yet to make their mark in the field.

support the basil hetzel institute

learn more about how you are making an impact

New Hope for Metastatic Breast Cancer

Thanks to the incredible generosity of one of our very special donors, Dr Margaret Elcombe, our researchers have been awarded the Elcombe Pre-Clinical Project Grant to pursue a promising new treatment avenue for breast cancer that has spread which if successful would be far less toxic than current treatments. read more

Developing Vaccines Against Viruses to Save Lives

Supported by The Hospital Research Foundation (THRF), Dr Ashish Shrestha’s research aims to develop a universal Hepatitis C virus vaccine and a DNA vaccine to provide effective protection against the Zika virus, currently there are no developed vaccines against either virus. read more

Helping Your Community Age Healthily

The proud recipient of The Hospital Research Foundation’s Mid-Career Fellowship for 2017, geographer and researcher Dr Danielle Taylor is kick-starting a three year project aimed at ensuring our community can live longer, healthier and more fulfilling lives in the comfort of their own homes. read more

Innovative Gel to Treat Chronic Back Pain

With the support of our Development Grant of $200,000 Professor Peter-John Wormald and his team are translating a gel now used to treat inflammation after sinus infection to a new treatment for people living with chronic pain after back surgery. read more

PhD Finding to Potential Breast Cancer Treatment

In 2015 we introduced you to the incredible work of Dr Bill Panagopoulos, who was leading world-first research into an enzyme believed to play an essential role in the spread of breast cancer to the bone. Finishing his PhD last year, we’re excited to share with you the results of his research as he moves one step closer to a new treatment for secondary breast cancer. read more